(Q41922298)

English

Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss

scientific article published on January 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

catastrophic antiphospholipid syndrome

0 references

0 references

hydroxychloroquine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Nataliya Mar

1

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Rebecca Kosowicz

2

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Karen Hook

3

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

publication date

1 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Journal of Thrombosis and Thrombolysis

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

196-200

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

https://scigraph.springernature.com/pub.10.1007/s11239-014-1061-x

0 references

Antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Antiphospholipid antibodies and antithrombin deficiency: double trouble for pregnancy

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Intravenous immunoglobulin to prevent recurrent thrombosis in the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Intravenous immunoglobulin therapy of antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Immunomodulatory effects of intravenous immunoglobulins as a treatment for autoimmune diseases, cancer, and recurrent pregnancy loss

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

The pathogenesis of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Treatment of pregnant patients with antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

The hematologic manifestations of the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Thrombocytopenia in patients with systemic lupus erythematosus: significant in the clinical implication and prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1061-X

21 January 2018

Risk factors for venous thromboembolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiphospholipid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of an Fc gamma receptor-independent mechanism by which intravenous immunoglobulin ameliorates antiphospholipid antibody-induced thrombogenic phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypercoagulability and thrombosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Catastrophic antiphospholipid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiphospholipid syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side-effects of intravenous immune globulins

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombocytopenia as a sensitive marker of immunologic activity in a patient with autoimmune chronic active hepatitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiphospholipid Syndrome during pregnancy: the state of the art

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24549974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11239-014-1061-X

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41922298&oldid=1929909397"